138 related articles for article (PubMed ID: 6163222)
1. Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparin.
Vinazzer H; Haas S; Stemberger A
Thromb Res; 1980 Oct; 20(1):57-68. PubMed ID: 6163222
[No Abstract] [Full Text] [Related]
2. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
3. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
4. Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man.
Ryde M; Eriksson H; Tangen O
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):435-45. PubMed ID: 6172879
[No Abstract] [Full Text] [Related]
5. Anticoagulant activities of a pentosane polysulphate: comparison with standard heparin and a fraction of low molecular weight heparin.
Soria C; Soria J; Ryckewaert JJ; Holmer E; Caen JP
Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):455-63. PubMed ID: 6160640
[No Abstract] [Full Text] [Related]
6. Isolation and anticoagulant properties of a new sulfated xylan: comparison with heparin and a sodium pentosan polysulfate (SP-54).
Doctor VM; Sauls V
Thromb Res; 1983 Jun; 30(6):573-8. PubMed ID: 6193601
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of sodium pentosan polysulphate in man measured by a new competitive binding assay for sulphated polysaccharides--comparison with effects upon anticoagulant activity, lipolysis and platelet alpha-granule proteins.
MacGregor IR; Dawes J; Pepper DS; Prowse CV; Stocks J
Thromb Haemost; 1985 Jun; 53(3):411-4. PubMed ID: 2413564
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen binding on human platelets. Influence of different heparins and of pentosane polysulfate.
Dunn F; Soria J; Soria C; Thomaidis A; Tobelem G; Caen JP
Thromb Res; 1983 Jan; 29(2):141-8. PubMed ID: 6189236
[TBL] [Abstract][Full Text] [Related]
9. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
Scully MF; Kakkar VV
Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
[TBL] [Abstract][Full Text] [Related]
10. Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo.
Esquivel CO; Bergqvist D; Björck CG; Nilsson B
Thromb Res; 1982 Nov; 28(3):389-99. PubMed ID: 6184845
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
Van Ryn-McKenna J; Gray E; Weber E; Ofosu FA; Buchanan MR
Thromb Haemost; 1989 Feb; 61(1):7-9. PubMed ID: 2473537
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacology of a heparinoid derived from pentosan].
Lansen J; Diner H
Agressologie; 1983 Dec; 24(12):591-5. PubMed ID: 6199994
[No Abstract] [Full Text] [Related]
13. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
[TBL] [Abstract][Full Text] [Related]
14. Pentosan polysulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro.
Baba M; Nakajima M; Schols D; Pauwels R; Balzarini J; De Clercq E
Antiviral Res; 1988 Sep; 9(6):335-43. PubMed ID: 2465736
[TBL] [Abstract][Full Text] [Related]
15. The effect of a sulfated polysaccharide on antithrombin III.
Czapek EE; Kwaan HC; Szczecinski M
J Lab Clin Med; 1980 Jun; 95(6):783-90. PubMed ID: 6155418
[TBL] [Abstract][Full Text] [Related]
16. Induction of fibrinolysis by polyanions in human plasma.
Klauser RJ
Thromb Haemost; 1988 Oct; 60(2):324-7. PubMed ID: 2464201
[TBL] [Abstract][Full Text] [Related]
17. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
Scully MF; Kakkar VV
Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
[TBL] [Abstract][Full Text] [Related]
18. The effect of pentosan polysulphate (SP54) on the human fibrinolytic system.
Gaffney PJ; Marsh NA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):262-71. PubMed ID: 2427409
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.
Modi NB; Kell S; Simon M; Vargas R
J Clin Pharmacol; 2005 Aug; 45(8):919-26. PubMed ID: 16027402
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the lipolytic and anticoagulative properties of heparin and pentosan polysulphate in the thoroughbred horse.
Orme CE; Harris RC
Acta Physiol Scand; 1997 Feb; 159(2):179-85. PubMed ID: 9055947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
